Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China

Reuters

06-05

<a href="https://laohu8.com/S/BPMUF">Basilea Pharmaceutica AG</a> and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China

Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2541488540"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541488540\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2541488540?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 13:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541488540","market":"nz","top_or_hot":-1,"title":"Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BPMUF\">Basilea Pharmaceutica AG</a> and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBasilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-05 13:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BPMUF\">Basilea Pharmaceutica AG</a> and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"輝瑞","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL9MB7Ds:1","article_id":"2541488540","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541488540","pubTimestamp":1749100522,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China. Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe , China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba . The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide a","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞","NDAQ":"纳斯达克OMX交易所"},"translate_title":"Basilea Pharmaceutica AG和辉瑞加强合作伙伴关系，为Cresemba在亚太地区和中国的销售支付里程碑付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"PFE":0.9},"content_text":"Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n    \n\n        Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,express","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}